Here are four things to know:
1. The company’s stock currently has a consensus rating of “buy” and an average price target is $112.
2. Stryker’s most recent report showed net sales were up slightly in the third quarter of 2015. The consolidated net sales were $2.4 billion in the third quarter, a 1.3 percent increase.
3. Michael Matson, analyst at Needham, stated “We have lowered our EPS estimates given a 2016 currency headwind of $0.10-$0.15.”
4. However, corporate insider sentiment is positive on the stock, based on the recent corporate insider activity of 120 insiders.
More articles on devices:
MidCap Business Credit becomes SpineFrontier’s lending partner — 3 quick notes
OrthAlign to launch OrthAlign Plus for direct anterior hip replacement — 4 things to know
Burton’s new Outpatient LED Examination Light has arrived
